Michael Pennison - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael Pennison

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Current Opinion in Oncology|October 2, 2007

Targeting transforming growth factor-beta signalingMichael Pennison, Boris Pasche

Seminars in Oncology|July 16, 2014

Prevention and treatment of cancer with aspirin: where do we stand?Boris Pasche, Minghui Wang, Michael Pennison, et al.

Cancer Research|January 17, 2009

Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer developmentQinghua Zeng, Sharbani Phukan, Yanfei Xu, et al.

Oncotarget|October 13, 2025

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fieldsHugo Jimenez, Denise Gibo, Sambad Sharma, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Current Opinion in Oncology|October 2, 2007

Targeting transforming growth factor-beta signalingMichael Pennison, Boris Pasche

Seminars in Oncology|July 16, 2014

Prevention and treatment of cancer with aspirin: where do we stand?Boris Pasche, Minghui Wang, Michael Pennison, et al.

Cancer Research|January 17, 2009

Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer developmentQinghua Zeng, Sharbani Phukan, Yanfei Xu, et al.

Oncotarget|October 13, 2025

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fieldsHugo Jimenez, Denise Gibo, Sambad Sharma, et al.

Pageof 1